Copper prevents amyloid-β1–42 from forming amyloid fibrils under near-physiological conditions in vitro
Open accessThe DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Abstract
The aggregation and deposition of amyloid-β((1-42) )(Aβ(42)) in the brain is implicated in the aetiology of Alzheimer's disease (AD). While the mechanism underlying its deposition in vivo is unknown its precipitation in vitro is influenced by metal ions. For example, Aβ(42) is known to bind copper, Cu(II), in vitro and binding results in aggregation of the peptide. The biophysical properties of Cu(II)-Aβ(42) aggregates are of significant importance to their putative involvement in the amyloid cascade hypothesis of AD and are currently the subject of strong debate. In particular the question has been raised if sub- and super-stoichiometric concentrations of Cu(II) act in opposing ways in respectively accelerating and preventing amyloid fibril formation by Aβ(42). Herein we have used fluorimetry and transmission electron microscopy to provide unequivocal evidence that under near-physiological conditions both sub- and super-stoichiometric concentrations of Cu(II) prevented the assembly of Aβ(42) into ThT-positive β-sheet rich amyloid fibrils.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In plaques from persons with Alzheimer’s disease, iron and aluminum appear to cause plaque formation while copper and zinc may be protective [26,27,28,35,36,37].”
From The Effect of the Human Peptide GHK on Gene Expression Relevant to Nervous System Function and Cognitive Decline (2017) · cites this paper as [28]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In inhibition experiments, a reduced ThT fluorescence was observed for the Cu2+- and Zn2+-containing fibrils, as reported previously (Figure 6).21,49,50”
From Small Bifunctional Chelators That Do Not Disaggregate Amyloid β Fibrils Exhibit Reduced Cellular Toxicity (2014) · cites this paper as [49]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Several studies showed that Zn2+ promotes formation of nonfibrillar aggregates,16,29–31 yet conflicting results have been reported for the Cu2+-mediated Aβ aggregation.21,28,32,33”
From The effect of Cu2+ and Zn2+ on the Aβ42 peptide aggregation and cellular toxicity (2013) · cites this paper as [28]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Atwood, C. S., Scarpa, R. C., Huang, X., Moir, R. D., Jones, W. D., Fairlie, D. P., Tanzi, R. E., & Bush, A. I. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751219.x · Cited by 641
Viles, J. H. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.05.003 · Cited by 404
House, E., Collingwood, J., Khan, A., Korchazkina, O., Berthon, G., & Exley, C. (2004) · Journal of Alzheimer's Disease · doi:10.3233/jad-2004-6310 · Cited by 294
Self-citationThe role of metallobiology and amyloid-β peptides in Alzheimer's disease
Roberts, B. R., Ryan, T. M., Bush, A. I., Masters, C. L., & Duce, J. A. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07500.x · Cited by 266
Schrag, M., Mueller, C., Oyoyo, U., Smith, M. A., & Kirsch, W. M. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.05.001 · Cited by 263
New Insights on How Metals Disrupt Amyloid β-Aggregation and Their Effects on Amyloid-β Cytotoxicity
Yoshiike, Y., Tanemura, K., Murayama, O., Akagi, T., Murayama, M., Sato, S., Sun, X., Tanaka, N., & Takashima, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010706200 · Cited by 244
Ha, C., Ryu, J., & Park, C. B. (2007) · Biochemistry · doi:10.1021/bi7000032 · Cited by 231
Regulation of solute and water balance and cell volume in the central nervous system.
Strange, K. (1992) · Journal of the American Society of Nephrology · doi:10.1681/asn.v3112 · Cited by 231
Copper signaling in the mammalian nervous system: Synaptic effects
Gaier, E. D., Eipper, B. A., & Mains, R. E. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23143 · Cited by 209
Sarell, C. J., Syme, C. D., Rigby, S. E. J., & Viles, J. H. (2009) · Biochemistry · doi:10.1021/bi900254n · Cited by 208
Sarell, C. J., Wilkinson, S. R., & Viles, J. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.171355 · Cited by 199
Smith, D. P., Ciccotosto, G. D., Tew, D. J., Fodero-Tavoletti, M. T., Johanssen, T., Masters, C. L., Barnham, K. J., & Cappai, R. (2007) · Biochemistry · doi:10.1021/bi0620961 · Cited by 194
Metal ions as modulators of protein conformation and misfolding in neurodegeneration
Leal, S. S., Botelho, H. M., & Gomes, C. M. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.04.004 · Cited by 183
Hureau, C. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.03.037 · Cited by 178
Aluminum, copper, iron and zinc differentially alter amyloid-Aβ1–42 aggregation and toxicity
Bolognin, S., Messori, L., Drago, D., Gabbiani, C., Cendron, L., & Zatta, P. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.02.009 · Cited by 161
Binding of Zn(II), Cu(II), and Fe(II) ions to alzheimer's Aß peptide studied by fluorescence
Garzon-Rodriguez, W., Yatsimirsky, A. K., & Glabe, C. G. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00357-1 · Cited by 148
Jiang, D., Rauda, I. E., Han, S., Chen, S., & Zhou, F. (2012) · Langmuir · doi:10.1021/la3021436 · Cited by 121
Metal binding sites in amyloid oligomers: Complexes and mechanisms
Miller, Y., Ma, B., & Nussinov, R. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2011.12.022 · Cited by 105
Copper(II) inhibits the formation of amylin amyloid in vitro
Ward, B., Walker, K., & Exley, C. (2007) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2007.09.010 · Cited by 102
Self-citationKhan, A., Dobson, J., & Exley, C. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.09.013 · Cited by 100
Self-citationThioflavin T Promotes Aβ(1–40) Amyloid Fibrils Formation
D’Amico, M., Carlo, M. G. D., Groenning, M., Militello, V., Vetri, V., & Leone, M. (2012) · The Journal of Physical Chemistry Letters · doi:10.1021/jz300412v · Cited by 92
Innocenti, M., Salvietti, E., Guidotti, M., Casini, A., Bellandi, S., Foresti, M. L., Gabbiani, C., Pozzi, A., Zatta, P., & Messori, L. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1338 · Cited by 88
Effect of Cerebral Amyloid Angiopathy on Brain Iron, Copper, and Zinc in Alzheimer's Disease
Schrag, M., Crofton, A., Zabel, M., Jiffry, A., Kirsch, D., Dickson, A., Mao, X. W., Vinters, H. V., Domaille, D. W., Chang, C. J., et al. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-101503 · Cited by 79
Exley, C., House, E., Polwart, A., & Esiri, M. M. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-120766 · Cited by 59
Self-citationCopper Abolishes the β-Sheet Secondary Structure of Preformed Amyloid Fibrils of Amyloid-β42
House, E., Mold, M., Collingwood, J., Baldwin, A., Goodwin, S., & Exley, C. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1235 · Cited by 45
Self-citationOlofsson, A., Lindhagen‐Persson, M., Vestling, M., Sauer-Eriksson, A. E., & Öhman, A. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07113.x · Cited by 42
Metal-mediated formation of fibrillar ABri amyloid
Khan, A., Ashcroft, A. E., Korchazhkina, O. V., & Exley, C. (2004) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2004.09.004 · Cited by 37
Self-citationMantri, Y., Fioroni, M., & Baik, M. (2008) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-008-0403-6 · Cited by 36
Mold, M., Shrive, A. K., & Exley, C. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-120076 · Cited by 26
Self-citationChecler, F., & Turner, A. J. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07603.x · Cited by 20
Iron, copper and their proteins in substantia nigra of human brain during aging
Zecca, L., Zucca, F. A., Toscani, M., Adorni, F., Giaveri, G., Rizzio, E., & Gallorini, M. (2005) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1007/s10967-005-0650-8 · Cited by 19
Exley, C., Mold, M. J., Shardlow, E., Shuker, B., Ikpe, B., Wu, L., & Fraser, P. E. (2012) · journal of Diabetes Research and Clinical Metabolism · doi:10.7243/2050-0866-1-3 · Cited by 12
Self-citation(2001) · doi:10.1002/1521-3773(20010618)40:12<2274::aid-anie2274>3.0.co;2-5
Cited by
Biological metals and metal-targeting compounds in major neurodegenerative diseases
Barnham, K. J., & Bush, A. I. (2014) · Chem. Soc. Rev. · doi:10.1039/c4cs00138a · Cited by 497
Natural product-based amyloid inhibitors
Velander, P., Wu, L., Henderson, F., Zhang, S., Bevan, D. R., & Xu, B. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.04.004 · Cited by 202
“While there are still debates about the inhibitory or accelerating effects these metals may have on amyloid formation in vitro [87,89,90], it is”
BackgroundAlzheimer’s disease: How metal ions define β-amyloid function
Kepp, K. P. (2017) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2017.05.007 · Cited by 150
Metals and Neuronal Metal Binding Proteins Implicated in Alzheimer’s Disease
Cristóvão, J. S., Santos, R., & Gomes, C. M. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/9812178 · Cited by 146
Copper Toxicity Links to Pathogenesis of Alzheimer’s Disease and Therapeutics Approaches
Ejaz, H. W., Wang, W., & Lang, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207660 · Cited by 143
“While, the dietary copper addition leads to an increase of intracellular copper concentration in APP/PS1 AD mice [160], which has been shown in parenchymal Aβ plaques, a decrease of AD pathology, but no loss of neurons seen [152,153].”
Background
Metadata
- Authors
- Mold, M., Ouro-Gnao, L., Wieckowski, B. M., & Exley, C.
- Affiliations
- Keele University (GB)
- Corresponding author
- Exley, Christopher
- Venue
- Scientific Reports
- Published
- 2013-02-13
- Volume
- 3
- Issue
- 1
- Pages
- 1256-1256
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC3570782
- OpenAlex
- W2012108930
- Cited by
- 101
- References
- 35
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 3 · 2023: 2 · 2022: 8 · 2021: 12 · 2020: 10 · 2019: 10 · 2018: 8 · 2017: 12 · 2016: 9 · 2015: 9 · 2014: 7 · 2013: 5
- FWCI
- 6.94
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/3.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/3.0/ (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Engineering and Physical Sciences Research Council
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Keywords
- amyloid-beta 42, copper(II), amyloid fibril formation, Alzheimer's disease, metal ion binding, peptide aggregation, ThT fluorescence, beta-sheet, amyloid hypothesis
- MeSH terms
- Amyloid, Copper, Edetic Acid, Ions, Microscopy, Fluorescence, Peptide Fragments, Protein Binding, Amyloid beta-Peptides, Microscopy, Electron, Transmission
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.